Greenland Mines Ltd (NASDAQ: GRML) has announced the pricing of its previously announced public offering, which is expected to generate approximately $20 million in aggregate gross proceeds before placement agent fees and other offering expenses. The offering covers 4 million shares of common stock, or common stock equivalents, to new and existing mining-focused institutional investors and is expected to close on or about Aug. 27, 2026, subject to customary closing conditions.
The company intends to use the net proceeds to fund the acquisition of the Sarfartoq Nd-Pr Rare Earth Element Project, working capital, and other general corporate purposes. This acquisition is a key component of Greenland Mines' strategy to build a multi-asset platform with exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities.
The Sarfartoq project, located in southwest Greenland, is significant given the growing global demand for neodymium and praseodymium, which are essential for manufacturing permanent magnets used in electric vehicles, wind turbines, and other high-tech applications. By securing this project, Greenland Mines positions itself to play a role in the supply chain for these critical minerals, which are currently dominated by China.
The offering was led by A.G.P./Alliance Global Partners as the sole placement agent. The participation of new and existing mining-focused institutional investors underscores confidence in the company's strategic direction. The successful completion of this offering would provide Greenland Mines with the capital necessary to advance its rare earth project and strengthen its balance sheet.
This move aligns with broader efforts in Western economies to secure reliable sources of rare earth elements and reduce dependence on foreign suppliers. The company's vision of a North Atlantic Critical Metals Corridor linking Greenland resources with allied downstream jurisdictions could enhance supply chain resilience for the United States and its allies.
Investors should note that the offering is subject to customary closing conditions. The company's focus on rare earth elements, combined with its existing Skaergaard Project in southeast Greenland, which is rich in gold and platinum group metals, provides a diversified portfolio. Additionally, its biotech division, including Klotho's KLTO-202 for ALS, adds a unique dimension to the company's asset base.
For more details on the offering, interested parties can view the full press release at https://ibn.fm/iMYIM. The latest updates on Greenland Mines are available in the company's newsroom at https://ibn.fm/GRML.
